共 207 条
[1]
Lloyd-Jones DM(2002)Lifetime risk for developing congestive heart failure: the Framingham Heart Study Circulation 106 3068-3072
[2]
Larson MG(1998)Clinical epidemiology of heart failure: public and private health burden Eur Heart J 19 P9-P16
[3]
Leip EP(2012)A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting Clin Res Cardiol 101 1-10
[4]
Beiser A(1992)Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product J Am Coll Cardiol 20 1180-1186
[5]
D’Agostino RB(1996)Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity J Am Coll Cardiol 27 124-131
[6]
Kannel WB(1999)Intraventricular conduction delay: a prognostic marker in chronic heart failure Int J Cardiol 70 171-178
[7]
Murabito JM(2005)Significance of QRS complex duration in patients with heart failure J Am Coll Cardiol 46 2183-2192
[8]
Vasan RS(1991)Left ventricular hypertrophy as a risk factor: the Framingham experience J Hypertens Suppl 9 S3-S8
[9]
Benjamin EJ(2013)Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure Clin Res Cardiol 102 103-110
[10]
Levy D(2007)Systolic and diastolic heart failure: different phenotypes of the same disease? Eur J Heart Fail 9 136-143